• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Occlusion Devices Market

    ID: MRFR/MED/4478-HCR
    100 Pages
    Rahul Gotadki
    October 2025

    Occlusion Devices Market Research Report Information By Product (Occlusion Removal Devices, Embolization Devices, Tubal Occlusion Devices, and Support Devices), by Application (Neurology and Cardiology), by End-User (Hospitals & Clinics) – Global Forecast till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Occlusion Devices Market Infographic
    Purchase Options

    Occlusion Devices Market Summary

    The Global Occlusion Devices Market is projected to grow from 2.18 USD Billion in 2024 to 3.14 USD Billion by 2035.

    Key Market Trends & Highlights

    Occlusion Devices Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 3.37% from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 3.14 USD Billion, indicating robust growth potential.
    • In 2024, the market is valued at 2.18 USD Billion, reflecting a solid foundation for future expansion.
    • Growing adoption of innovative occlusion technologies due to increasing prevalence of cardiovascular diseases is a major market driver.

    Market Size & Forecast

    2024 Market Size 2.18 (USD Billion)
    2035 Market Size 3.14 (USD Billion)
    CAGR (2025-2035) 3.37%

    Major Players

    Cardinal Health, Cook Group, Edwards Lifesciences, Abbott Laboratories, Acrostak, MicroPort Scientific Corporation, Vascular Concepts, Elixir Medical Corporation, Kyoto Medical Planning, Terumo Corporation

    Occlusion Devices Market Trends

    Drivers

    The market drivers attempt to portray that the factors that involve the growing awareness also intend to state of the people have managed to benefit the devices by replacing the process over the life treatment devices. These devices have attempted to state that the rapid rise in the growth of medical procedures has been affected. Apart from that, the demand for minimal facilities of medical devices along with the global occlusion device of the market growth has been affected.

    Restraints

    One of the major factors of restraints states that the high cost of the devices, technical challenges, regulatory requirements, and the situations faced by the surgeons. Hence, it attempts to showcase that the importance of the occlusion devices along with the lack of uniform reimbursement of the policies has been hampered. This has affected the demand of the occlusion devices market.

    Opportunities

    The increasing prevalence of cardiovascular diseases and the rising demand for minimally invasive surgical procedures are driving the growth of the occlusion devices market, reflecting a shift towards advanced therapeutic solutions.

    U.S. Food and Drug Administration (FDA)

    Occlusion Devices Market Drivers

    Market Growth Projections

    The Global Occlusion Devices Market Industry is projected to experience substantial growth over the coming years. With an estimated market value of 2.18 USD Billion in 2024, the industry is on track to reach 3.14 USD Billion by 2035. This growth trajectory indicates a compound annual growth rate (CAGR) of 3.37% from 2025 to 2035. Such projections reflect the increasing demand for occlusion devices driven by advancements in technology, rising healthcare expenditures, and a growing emphasis on minimally invasive procedures. The market's expansion is likely to create opportunities for innovation and improved patient outcomes.

    Regulatory Support and Approvals

    Regulatory support and streamlined approval processes for medical devices are crucial factors influencing the Global Occlusion Devices Market Industry. Regulatory bodies are increasingly recognizing the need for efficient pathways to bring innovative occlusion devices to market. This support fosters an environment conducive to research and development, encouraging manufacturers to invest in new technologies. As a result, the market is expected to experience robust growth, with an emphasis on compliance and safety standards. The proactive stance of regulatory agencies may enhance the overall landscape for occlusion devices, facilitating their integration into clinical practice.

    Increasing Healthcare Expenditure

    Rising healthcare expenditure across various regions is a pivotal driver for the Global Occlusion Devices Market Industry. Governments and private sectors are investing more in healthcare infrastructure, which includes the procurement of advanced medical devices. This trend is particularly evident in emerging economies, where healthcare budgets are expanding to accommodate new technologies. As a result, the market is anticipated to grow, reaching 3.14 USD Billion by 2035. This increase in funding is likely to facilitate the adoption of occlusion devices, thereby enhancing treatment options for patients.

    Rising Prevalence of Cardiovascular Diseases

    The increasing incidence of cardiovascular diseases globally drives the demand for occlusion devices. As per recent statistics, cardiovascular diseases remain a leading cause of mortality, prompting healthcare systems to seek effective solutions. The Global Occlusion Devices Market Industry is expected to benefit from this trend, as occlusion devices play a crucial role in managing conditions such as atrial fibrillation and coronary artery disease. With the market projected to reach 2.18 USD Billion in 2024, the focus on innovative occlusion technologies is likely to intensify, addressing the urgent need for improved patient outcomes.

    Technological Advancements in Occlusion Devices

    Technological innovations are significantly influencing the Global Occlusion Devices Market Industry. The development of advanced materials and minimally invasive techniques enhances the efficacy and safety of occlusion devices. For instance, the introduction of bioresorbable occlusion devices offers promising alternatives to traditional options, potentially reducing complications. As the market evolves, these advancements are expected to contribute to a projected growth rate of 3.37% CAGR from 2025 to 2035. This growth reflects the industry's commitment to improving patient care through cutting-edge technology.

    Growing Awareness of Minimally Invasive Procedures

    The growing awareness and preference for minimally invasive procedures among patients and healthcare providers significantly impact the Global Occlusion Devices Market Industry. Patients increasingly seek treatments that offer reduced recovery times and lower risks of complications. Consequently, occlusion devices, which are often associated with minimally invasive techniques, are gaining traction. This shift in patient preference is likely to drive market growth, as healthcare providers adapt to meet these demands. The anticipated market expansion underscores the importance of aligning product offerings with evolving patient expectations.

    Key Companies in the Occlusion Devices Market market include

    Industry Developments

    • Q2 2024: Boston Scientific Announces FDA Approval of the EkoSonic Endovascular System for Pulmonary Embolism Boston Scientific received FDA approval for its EkoSonic Endovascular System, designed for the treatment of pulmonary embolism, expanding its portfolio of occlusion and embolization devices.
    • Q1 2024: Penumbra, Inc. Launches New RED Reperfusion Catheters for Occlusion Procedures in the U.S. Penumbra, Inc. announced the commercial launch of its latest RED Reperfusion Catheters in the United States, targeting improved outcomes in occlusion and thrombectomy procedures.
    • Q2 2024: Medtronic Receives CE Mark for Pipeline Vantage Embolization Device with Shield Technology Medtronic announced it has received CE Mark approval for its Pipeline Vantage Embolization Device with Shield Technology, intended for the treatment of brain aneurysms.
    • Q1 2024: Stryker Launches Target Tetra Detachable Coil for Neurovascular Occlusion in Europe Stryker announced the European launch of its Target Tetra Detachable Coil, a device designed for neurovascular occlusion procedures.
    • Q2 2024: Johnson & Johnson MedTech Acquires Laminar, Expanding Structural Heart Occlusion Portfolio Johnson & Johnson MedTech completed the acquisition of Laminar, a company specializing in left atrial appendage occlusion devices, to strengthen its structural heart business.
    • Q1 2024: FDA Approves Abbott’s Amplatzer Talisman PFO Occluder for Stroke Prevention Abbott received FDA approval for its Amplatzer Talisman PFO Occluder, a device indicated for the prevention of recurrent strokes in patients with a patent foramen ovale.
    • Q2 2024: Artio Medical Announces First Patient Treated in U.S. Clinical Study of Amplifi Vein Dilation System Artio Medical announced the first patient has been treated in a U.S. clinical study evaluating the Amplifi Vein Dilation System, an investigational device for vascular occlusion and access.
    • Q1 2024: Terumo Launches AZUR Vascular Plug in Japan for Peripheral Vessel Occlusion Terumo Corporation announced the launch of its AZUR Vascular Plug in Japan, expanding its offerings for peripheral vessel occlusion procedures.
    • Q2 2024: Penumbra Receives FDA Clearance for Indigo Aspiration System with Lightning 12 for Venous Occlusions Penumbra received FDA clearance for its Indigo Aspiration System with Lightning 12, designed for the removal of venous occlusions.
    • Q1 2024: Medtronic Launches Concerto Detachable Coil System for Embolization in the U.S. Medtronic announced the U.S. launch of its Concerto Detachable Coil System, intended for embolization procedures in neurovascular and peripheral vasculature.
    • Q2 2024: Boston Scientific Acquires Obsidio, Inc. to Expand Embolization Portfolio Boston Scientific completed the acquisition of Obsidio, Inc., a company developing novel embolization technology, to enhance its interventional oncology and peripheral interventions business.
    • Q1 2024: Abbott Receives CE Mark for Navitor Transcatheter Aortic Valve Implantation System with Occluder Technology Abbott announced CE Mark approval for its Navitor Transcatheter Aortic Valve Implantation System, which features occluder technology for improved valve sealing.

    Future Outlook

    Occlusion Devices Market Future Outlook

    The Global Occlusion Devices Market is projected to grow at a 3.37% CAGR from 2024 to 2035, driven by technological advancements, increasing prevalence of chronic diseases, and rising healthcare expenditures.

    New opportunities lie in:

    • Develop innovative occlusion devices tailored for minimally invasive procedures.
    • Expand into emerging markets with affordable, high-quality occlusion solutions.
    • Leverage digital health technologies to enhance patient monitoring and device performance.

    By 2035, the Occlusion Devices Market is expected to achieve substantial growth, reflecting evolving healthcare needs and technological advancements.

    Market Segmentation

    Occlusion Devices product Outlook

    • Embolization devices
    • Support devices
    • Removal devices

    Occlusion Devices End-User Outlook

    • Clinics
    • Surgical centres
    • Hospitals
    • Ambulatory care centres

    Occlusion Devices Application Outlook

    • Neurology
    • Oncology
    • Gynaecology
    • Cardiology

    Report Scope

    Report Attribute/Metric Details
    Market Size 2032 USD 2.43 Billion
    Compound Annual Growth Rate (CAGR) 8.90% (2024-2032)
    Base Year 2023
    Market Forecast Period 2024-2032
    Historical Data 2018- 2021
    Market Forecast Units Value (USD Billion)
    Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
    Segments Covered Product, Application & End-User
    Geographies Covered North America, Europe, Asia Pacific, and the Rest of the World
    Countries Covered The US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
    Key Companies Profiled Cardinal Health, Cook Group, Edwards Lifesciences, Abbott Laboratories, Acrostak, MicroPort Scientific Corporation, Vascular Concepts, Elixir Medical Corporation, Kyoto Medical Planning,Terumo Corporation
    Key Market Opportunities Growing prevalence of cardiovascular diseases globally, leading to increased demand for occlusion devices.
    Key Market Dynamics Increasing preference for minimally invasive procedures over traditional surgeries, boosting demand for occlusion devices.

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    What is the expected growth rate of the global occlusion devices market?

    Global occlusion devices market is expected to expand at 8.90% CAGR from 2024 to 2032.

    What are the biggest drivers of the global occlusion devices market?

    High prevalence of heart diseases and huge demand for its diagnosis are primary drivers of the global occlusion devices market.

    What is the restraining factor of the global occlusion devices market?

    Alternative treatment methods is the major factor expected to impede the global occlusion devices market growth.

    Which region can grow the fastest in the global occlusion devices market?

    APAC can showcase a robust CAGR in the global occlusion devices market till 2032 due to increasing focus on early detection of heart diseases.

    Who are the prominent players of the global occlusion devices market?

    Kyoto Medical Planning Co. Ltd., Translumina GmbH, Elixir Medical Corporation, Abbott Laboratories, Acrostak, Terumo Corporation, Stryker Corporation, Penumbra, Asahi Intecc, Edwards Lifesciences, Biosensors International Group, Ltd., Medtronic plc, Vascular Concepts, B. Braun Melsungen AG, Terumo Corporation, Cardinal Health, Avinger, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., Boston Scientific Corporation, Cook Group, and Angiodynamics are prominent players of the global occlusion devices market.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials